Table 2.
Site-specific bone mineral density (BMD) at visit 3** in relation to hemoglobin value and separately white blood cell (WBC) count in visit 2**
| BMD | Women | Men | ||
|---|---|---|---|---|
| Age, race, study site-adjusted β (95% CI) | Full model-adjusted β (95% CI)* | Age, race, study site-adjusted β (95% CI) | Full model-adjusted β (95% CI)* | |
| The association of Hgb and three BMD sites (in 102g/cm2), visit 2 (1992–1993) | ||||
| Per 1. SD (1.14g/dL) increase in Hgb | Per 1 SD (1.27g/dL) increase in Hgb | |||
| Total hip | 0.13 (−0.89, 1.16) | −0.49 (−1.57, 0.59) | −0.29 (−1.53, 0.96) | −0.60 (−1.88, 0.68) |
| Lumbar spine | 0.22 (−1.56, 2.00) | −0.40 (−2.57, 1.76) | −1.12 (−3.07, 0.82) | −1.69 (−3.83, 0.45) |
| Total body | −0.32 (−1.15, 0.50) | −0.64 (−1.57, 0.30) | −0.67 (−1.65, 0.3) | −0.91 (−1.98, 0.16) |
| The association of WBC and three BMD sites (in 102g/cm2), visit 2 (1992–1993) | ||||
| Per 1 SD (1.60×103μL) increase in WBC | Per 1 SD (1.54×103μL) increase in WBC | |||
| Total hip | 0.50 (−0.36, 1.37) | 0.74 (−0.22, 1.69) | −0.28(−1.53, 0.98) | −0.23(−1.51, 1.05) |
| Lumbar spine | 1.79 (0.29, 3.29) | 2.10 (0.19, 4.00) | −0.52 (−2.49, 1.44) | −0.47 (−2.62, 1.68) |
| Total body | 0.52 (−0.18, 1.21) | 0.64 (−0.19, 1.46) | −0.20 (−1.19, 0.78) | −0.47 (−2.62, 1.68) |
*
Full model adjusted for age, study site, African American race, current smoking, alcohol use (0, 1–7, more than 7), weight, height, steroid use (ever), estrogen use, thiazide use, physical activity score and self-reported health.
**
visit 2: 1992–1993, visit 3: 1994–1995